Gestational diabetes & diabetes in pregnancy

The need for pharmacotherapy among patients with one or more elevations on glucose tolerance test

J Clin Endocrinol MetabPublished Retrospective cohort study

Authors' conclusion

Among patients with 1 OGTT elevation, fasting elevation and BMI are predictive of need for anti-glycemic medications. Predictive models may be useful in assessing need for pharmacotherapy for patients with abnormal OGTT, not otherwise meeting criteria for gestational diabetes.

Study context

Population
Singleton gestations ≥24 weeks with at least 1 elevation on 3-hour oral glucose tolerance test (OGTT)
Participants
480 vs 376
Exposure
Timing, number and extent of OGTT elevations as predictors of need for pharmacotherapy
  • 1 OGTT elevationn = 480reference
  • ≥2 OGTT elevationsn = 376
Outcome
Need for pharmacotherapy for glycemic control
Methodological detailslogistic regression, predictive model based on linear discriminant analysis
  • Logistic regression
  • Predictive model based on linear discriminant analysis

Main finding

As reported in the abstract

1 OGTT elevation

19.2%

Observational data: associations, not effects.

Further findings

Predictive model (body mass index (BMI) and extent of elevation at each OGTT time point)

Increase in identification of patients requiring pharmacotherapy
15.4%

Original publication

The need for pharmacotherapy among patients with one or more elevations on glucose tolerance test. J Clin Endocrinol Metab. Published 12 February 2026. doi:10.1210/clinem/dgag062

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.